Aggregation and catabolism of disease-associated intra-Aβ mutations: reduced proteolysis of AβA21G by neprilysin
- 17 June 2008
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 31 (3) , 442-450
- https://doi.org/10.1016/j.nbd.2008.06.001
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AG027443)
- National Center for Research Resources
- Wellcome Trust (067660)
- Alzheimer's Association
This publication has 54 references indexed in Scilit:
- In vitro and in vivo degradation of Aβ peptide by peptidases coupled to erythrocytesPeptides, 2007
- Familial Alzheimer's disease mutations alter the stability of the amyloid β-protein monomer folding nucleusProceedings of the National Academy of Sciences, 2007
- Reducing Amyloid Plaque Burden via Ex Vivo Gene Delivery of an Aβ-Degrading Protease: A Novel Therapeutic Approach to Alzheimer DiseasePLoS Medicine, 2007
- Neprilysin protects neurons against Aβ peptide toxicityBrain Research, 2007
- Alzheimer's disease: Aβ, tau and synaptic dysfunctionTrends in Molecular Medicine, 2005
- Differential Degradation of Amyloid β Genetic Variants Associated with Hereditary Dementia or Stroke by Insulin-degrading EnzymePublished by Elsevier ,2003
- Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivoNature, 2002
- The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formationNature Neuroscience, 2001
- Amyloid β-Protein FibrillogenesisJournal of Biological Chemistry, 1997
- Comparison of the structure and expression of the human and rat neprilysin (endopeptidase 24.11)-encoding genesGene, 1995